Epstein-Barr virus: Is there any contribution to chronic hepatitis B and C?

Liver International

Volumn 30, Issue 3, 2010, Pages 488-489

  Petrova, Mihaela ^a   Kamburov, Victor ^b   Nikolovska, Diana ^a   Kosseva, Olga ^c   Nikolova, Maria ^d   Krastev, Zahariy ^c  

^a Medical Institute   (Bulgaria)

^b Second Multiprofile Active Treatment Hospital   (Bulgaria)

^c UNIVERSITY HOSPITAL ST IVAN RILSKI   (Bulgaria)

^d NATIONAL CENTER OF INFECTIOUS AND PARASITIC DISEASES   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; VIRUS DNA; VIRUS RNA;

ADULT; CHRONIC LIVER DISEASE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; VIREMIA; VIRUS LOAD; VIRUS REACTIVATION;

ADOLESCENT; ADULT; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HERPESVIRUS 4, HUMAN; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 77950623959     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2009.02138.x     Document Type: Letter

References (8)

1. Hess RD. Routine Epstein-Barr virus diagnostics from the laboratory perspective: still challenging after 35 years. J Clin Microbiol 2004, 42:3381-7.
2. Arcenas R, Widen RH. Epstein-Barr virus reactivation after superinfection of the BJAB-B1 and P3HR-1 cell lines with cytomegalovirus. BMC Microbiol 2002, 2:20.
3. Jabs WJ, Wagner HJ, Sclenke P, Kirchner H. The primary and memory immune response to Epstein-Barr virus infection in vitro is characterized by a divergent production of IL-1β/IL-6 and IL-10. Scand J Immunol 2000, 52:304-8.
4. Nelson DR, Tu Z, Soldevila-Pico C. Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect. Hepatology 2003, 38:859-68.
5. Guidotti LG, Rochford R, Chung J. Viral clearance without destruction of infected cells during acute HBV infection. Science 1999, 284:825-9.
6. Santolamazza M, Marinelli RM, Bacosi M. What kind of hepatitis? J Int Med Res 2001, 5:441-4.
7. Sugawara Y, Makuuchi M, Kato N, Shimotohno K, Takada K. Enhancement of hepatitis C virus replication by Epstein-barr virus-encoded nuclear antigen 1. EMBO J 1999, 20:5755-60.
8. Doisne JM, Urrutia A, Lacabaratz-Porret C. CD8+T cells specific for EBV, cytomegalovirus, and influenza virus are activated during primary HIV infection. J Immunol 2004, 4:2410-8.